Paper21765641
Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain.
Lu B and 5 others. J Biomed Biotechnol, 2011. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain. Papers, record 21765641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21765641
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain.
- PubMed
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Neutralizing | Major topic |
| Immunity, Mucosal | Major topic |
| Smallpox Vaccine | Major topic |
| Vaccinia | Major topic |
| Vaccinia virus | Major topic |
| Administration, Intranasal | |
| Administration, Oral | |
| Animals | |
| Antibodies, Viral | |
| Female | |
| Immunization | |
| Injections, Intramuscular | |
| Injections, Subcutaneous | |
| Mice | |
| Mice, Inbred BALB C | |
| Smallpox | |
| Vaccination | |
| Vaccines, Attenuated | |
| Variola virus |
Source PubMed
References39
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20045097 | One time intranasal vaccination with a modified vaccinia Tiantan strain MVTT(ZCI) protects animals against pathogenic viral challenge. | Vaccine | 2010 | https://conductscience.org/library/papers/20045097 | PubMed |
| 2 | 788150 | The eradication of smallpox. | Sci Am | 1976 | https://conductscience.org/library/papers/788150 | PubMed |
| 3 | 10200293 | Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/10200293 | PubMed |
| 4 | 16759767 | Evaluation of fowlpox-vaccinia virus prime-boost vaccine strategies for high-level mucosal and systemic immunity against HIV-1. | Vaccine | 2006 | https://conductscience.org/library/papers/16759767 | PubMed |
| 5 | 21994611 | The development of an AIDS mucosal vaccine. | Viruses | 2010 | https://conductscience.org/library/papers/21994611 | PubMed |
| 6 | 10229229 | Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations. | Nat Med | 1999 | https://conductscience.org/library/papers/10229229 | PubMed |
| 7 | 18093703 | Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus. | Vaccine | 2008 | https://conductscience.org/library/papers/18093703 | PubMed |
| 8 | 19159014 | A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination. | PLoS One | 2009 | https://conductscience.org/library/papers/19159014 | PubMed |
| 9 | 18234801 | Redundancy and plasticity of neutralizing antibody responses are cornerstone attributes of the human immune response to the smallpox vaccine. | J Virol | 2008 | https://conductscience.org/library/papers/18234801 | PubMed |
| 10 | 17581748 | Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus. | Appl Microbiol Biotechnol | 2007 | https://conductscience.org/library/papers/17581748 | PubMed |
| 11 | 12201305 | Responses to smallpox vaccine. | N Engl J Med | 2002 | https://conductscience.org/library/papers/12201305 | PubMed |
| 12 | 18398296 | Protective immunity following vaccination: how is it defined? | Hum Vaccin | 2008 | https://conductscience.org/library/papers/18398296 | PubMed |
| 13 | 12970455 | Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein. | J Virol | 2003 | https://conductscience.org/library/papers/12970455 | PubMed |
| 14 | 12856218 | Smallpox vaccination: a review, part II. Adverse events. | Clin Infect Dis | 2003 | https://conductscience.org/library/papers/12856218 | PubMed |
| 15 | 15708987 | Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. | J Virol | 2005 | https://conductscience.org/library/papers/15708987 | PubMed |
| 16 | 15951823 | Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus. | Nat Med | 2005 | https://conductscience.org/library/papers/15951823 | PubMed |
| 17 | 16168312 | Smallpox. | Crit Care Clin | 2005 | https://conductscience.org/library/papers/16168312 | PubMed |
| 18 | 19500964 | Heterologous prime-boost vaccination. | Curr Opin Immunol | 2009 | https://conductscience.org/library/papers/19500964 | PubMed |
| 19 | 17529982 | Lymphoid reservoirs of antigen-specific memory T helper cells. | Nat Immunol | 2007 | https://conductscience.org/library/papers/17529982 | PubMed |
| 20 | 18061316 | Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses. | Vaccine | 2007 | https://conductscience.org/library/papers/18061316 | PubMed |
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41589837 | Protective efficacy of a genetically modified attenuated vaccinia virus Tiantan strain against monkeypox virus challenge in a small animal model. | J Virol | 2026 | https://conductscience.org/library/papers/41589837 | PubMed |
| 37822719 | A T cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection. | Mol Ther Methods Clin Dev | 2023 | https://conductscience.org/library/papers/37822719 | PubMed |
| 35935962 | Immunogenicity of a vaccinia virus-based severe acute respiratory syndrome coronavirus 2 vaccine candidate. | Front Immunol | 2022 | https://conductscience.org/library/papers/35935962 | PubMed |
| 34687845 | Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection. | Mol Ther | 2022 | https://conductscience.org/library/papers/34687845 | PubMed |
| 32698399 | IMVAMUNE® and ACAM2000® Provide Different Protection against Disease When Administered Postexposure in an Intranasal Monkeypox Challenge Prairie Dog Model. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/32698399 | PubMed |
| 24050999 | Systemically administered DNA and fowlpox recombinants expressing four vaccinia virus genes although immunogenic do not protect mice against the highly pathogenic IHD-J vaccinia strain. | Virus Res | 2013 | https://conductscience.org/library/papers/24050999 | PubMed |
| 23994378 | The effects of post-exposure smallpox vaccination on clinical disease presentation: addressing the data gaps between historical epidemiology and modern surrogate model data. | Vaccine | 2013 | https://conductscience.org/library/papers/23994378 | PubMed |
| 23593246 | Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan, the Chinese smallpox vaccine strain. | PLoS One | 2013 | https://conductscience.org/library/papers/23593246 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21765641
GET https://conductscience.org/api/papers/v1/21765641/references?page=2